Styrbjörn Byström

438 total citations
15 papers, 346 citations indexed

About

Styrbjörn Byström is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Styrbjörn Byström has authored 15 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Styrbjörn Byström's work include Chemical Synthesis and Analysis (2 papers), Carbohydrate Chemistry and Synthesis (2 papers) and Protein Tyrosine Phosphatases (2 papers). Styrbjörn Byström is often cited by papers focused on Chemical Synthesis and Analysis (2 papers), Carbohydrate Chemistry and Synthesis (2 papers) and Protein Tyrosine Phosphatases (2 papers). Styrbjörn Byström collaborates with scholars based in Sweden and France. Styrbjörn Byström's co-authors include Torbjörn Norin, Hans‐Erik Högberg, Jan‐E. Bäckvall, Hai Dong, Zhichao Pei, Olof Ramström, Robert Aslanian, Marcus Angelin, Johan Schultz and Stephen R. James and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Styrbjörn Byström

15 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Styrbjörn Byström Sweden 8 220 185 35 32 24 15 346
Mihály Szécsi Hungary 18 337 1.5× 322 1.7× 15 0.4× 45 1.4× 12 0.5× 46 664
Piotr Raubo United Kingdom 18 494 2.2× 316 1.7× 28 0.8× 17 0.5× 52 2.2× 41 746
J.K.Y. Wong United States 11 238 1.1× 272 1.5× 24 0.7× 61 1.9× 20 0.8× 28 498
Hiroshi Itazaki Japan 9 175 0.8× 228 1.2× 22 0.6× 38 1.2× 16 0.7× 15 416
Anne Birmingham United States 8 169 0.8× 317 1.7× 10 0.3× 68 2.1× 42 1.8× 8 579
Werner Breitenstein Switzerland 13 146 0.7× 163 0.9× 29 0.8× 40 1.3× 7 0.3× 20 387
Alexander Sudau Germany 10 232 1.1× 138 0.7× 53 1.5× 6 0.2× 17 0.7× 13 361
David Crowe United States 11 238 1.1× 142 0.8× 23 0.7× 19 0.6× 30 1.3× 33 389
Bainian Feng China 14 282 1.3× 181 1.0× 5 0.1× 30 0.9× 28 1.2× 38 477
Xingrui He China 13 117 0.5× 245 1.3× 13 0.4× 117 3.7× 12 0.5× 27 444

Countries citing papers authored by Styrbjörn Byström

Since Specialization
Citations

This map shows the geographic impact of Styrbjörn Byström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Styrbjörn Byström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Styrbjörn Byström more than expected).

Fields of papers citing papers by Styrbjörn Byström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Styrbjörn Byström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Styrbjörn Byström. The network helps show where Styrbjörn Byström may publish in the future.

Co-authorship network of co-authors of Styrbjörn Byström

This figure shows the co-authorship network connecting the top 25 collaborators of Styrbjörn Byström. A scholar is included among the top collaborators of Styrbjörn Byström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Styrbjörn Byström. Styrbjörn Byström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Daneshmanesh, Amir Hossein, Mohammad Hojjat‐Farsangi, Ali Moshfegh, et al.. (2018). A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib. PLoS ONE. 13(6). e0198038–e0198038. 31 indexed citations
2.
Hojjat‐Farsangi, Mohammad, Amir Hossein Daneshmanesh, Fariba Mozaffari, et al.. (2017). First-in-Class Oral Small Molecule Against the Tyrosine Kinase ROR1 (KAN0439834) Induced Significant Apoptosis of Chronic Lymphocytic Leukemia Cells. Blood. 130. 4320–4320. 1 indexed citations
3.
Mellstedt, Håkan, Mohammad Hojjat‐Farsangi, Amir Hossein Daneshmanesh, et al.. (2015). A new class of anti-cancer drugs targeting the tyrosine kinase receptor ROR1 in CLL.. Journal of Clinical Oncology. 33(15_suppl). 8556–8556. 3 indexed citations
4.
Mellstedt, Håkan, Amir Hossein Daneshmanesh, Ali Moshfegh, et al.. (2014). A new class of compound for pancreatic carcinoma targeting the tyrosine kinase receptor (TKR) ROR1.. Journal of Clinical Oncology. 32(15_suppl). e13561–e13561. 4 indexed citations
5.
Mellstedt, Håkan, Styrbjörn Byström, Johan Schultz, et al.. (2012). Effect of ROR1-targeting small molecules on chronic lymphocytic leukemia (CLL) cells.. Journal of Clinical Oncology. 30(15_suppl). 6557–6557. 6 indexed citations
6.
Dong, Hai, Zhichao Pei, Styrbjörn Byström, & Olof Ramström. (2007). Reagent-Dependent Regioselective Control in Multiple Carbohydrate Esterifications. The Journal of Organic Chemistry. 72(4). 1499–1502. 36 indexed citations
7.
Dong, Hai, Zhichao Pei, Marcus Angelin, Styrbjörn Byström, & Olof Ramström. (2007). Efficient Synthesis of β-d-Mannosides and β-d-Talosides by Double Parallel or Double Serial Inversion. The Journal of Organic Chemistry. 72(10). 3694–3701. 48 indexed citations
8.
Tjernberg, Agneta, Dan Hallén, Johan Schultz, et al.. (2004). Mechanism of action of pyridazine analogues on protein tyrosine phosphatase 1B (PTP1B). Bioorganic & Medicinal Chemistry Letters. 14(4). 891–895. 28 indexed citations
9.
Liljebris, Charlotta, Paweł Baranczewski, Eva Björkstrand, et al.. (2004). Oxidation of Protein Tyrosine Phosphatases as a Pharmaceutical Mechanism of Action: A Study Using 4-Hydroxy-3,3-dimethyl-2 H-benzo[g]indole-2,5(3 H)-dione. Journal of Pharmacology and Experimental Therapeutics. 309(2). 711–719. 20 indexed citations
10.
Byström, Styrbjörn, et al.. (2002). Synthesis and characterization of surface‐active compounds derived from cholesterol derivatives and glucose. Journal of Surfactants and Detergents. 5(4). 345–351. 6 indexed citations
11.
Nyström, Jan-Erik, et al.. (1988). Functionalization of 6,6-Dimethylfulvene: A Fulvene Analogue of the Aldol Condensation.. Tetrahedron Letters. 29(39). 4997–5000. 4 indexed citations
12.
Byström, Styrbjörn, Robert Aslanian, & Jan‐E. Bäckvall. (1985). Synthesis of protected allylamines via palladium-catalyzed amide addition to allylic substrates. Tetrahedron Letters. 26(14). 1749–1752. 54 indexed citations
13.
Bäckvall, Jan‐E., Eva Björkman, Styrbjörn Byström, & Arlette Solladié‐Cavallo. (1982). Palladium-promoted asymetric oxyamination of alkenes application to the synthesis of optically active aryloxypropanolamines. Tetrahedron Letters. 23(9). 943–946. 14 indexed citations
14.
Byström, Styrbjörn, Hans‐Erik Högberg, & Torbjörn Norin. (1981). Chiral synthesis of (2s,3s,7s)-3,7-dimethylpentadecan-2-yl acetate and propionate, potential sex pheromone components of the pine saw-fly neodiprion sertifer (geoff.). Tetrahedron. 37(12). 2249–2254. 84 indexed citations
15.
Åkermark, Björn, et al.. (1974). Strained Heterocyclic Compounds. 5. The Synthesis of [Bromochloro(N,N-pentamethylenecarbamoyl)methyl]-phenylmercury and Its Thermal Decomposition to a Chloro-beta-lactam.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 28b(3). 375–376. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026